Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 3/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 2/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL719933 | 0.91 | USP2 (0.47) | USP2GNAI3GNAO1GNAI1KDM4E | |
| SCHEMBL720551 | 0.91 | USP2 (0.47) | USP2GNAI3GNAO1GNAI1KDM4E | |
| SCHEMBL9207978 | 0.82 | PPARA (0.45) | KDM4EALDH1A1FAAHTRPV1PPARA | |
| SCHEMBL26940946 | 0.81 | USP2 (0.46) | USP2GNAI3GNAO1GNAI1KDM4E | |
| SCHEMBL14886898 | 0.81 | FAAH (0.39) | KDM4EALDH1A1FAAHMGLL | |
| SCHEMBL13975980 | 0.80 | FAAH (0.38) | FAAHMGLL | |
| SCHEMBL15805644 | 0.80 | FAAH (0.38) | FAAHMGLL | |
| SCHEMBL26941612 | 0.79 | CARM1 (0.41) | USP2GNAI3GNAO1GNAI1KDM4E | |
| SCHEMBL20333633 | 0.78 | USP2 (0.43) | USP2GNAI3GNAO1GNAI1KDM4E | |
| SCHEMBL15786163 | 0.78 | TRPV1 (0.37) | FAAHTRPV1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384508-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-06-19 | — | — | EP | claimed |
| WO-2024031051-A1 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-02-08 | — | — | WO | claimed |
| US-11866723-B2 | Plant virus movement proteins and methods of using same | Molecular Transfer Inc. (US) | 2024-01-09 | — | — | US | claimed |
| EP-4175967-A2 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation (US) | 2023-05-10 | — | — | EP | claimed |
| WO-2023018990-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2023-02-16 | — | — | WO | claimed |
| WO-2022006368-A2 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation (US) | 2022-01-06 | — | — | WO | claimed |
| US-10968240-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2021-04-06 | — | — | US | claimed |
| US-10155780-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2018-12-18 | — | — | US | claimed |
| US-20170029448-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2017-02-02 | — | — | US | claimed |
| EP-2912045-A2 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2015-09-02 | — | — | EP | claimed |
| WO-2014070687-A2 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2014-05-08 | — | — | WO | claimed |
| EP-2696678-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2014-02-19 | — | — | EP | claimed |
| WO-2013158127-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2013-10-24 | — | — | WO | claimed |
| EP-2015780-B1 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER INC (US) | 2012-12-12 | — | — | EP | claimed |
| WO-2012142622-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2012-10-18 | — | — | WO | claimed |
| US-7915230-B2 | Reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2011-03-29 | — | — | US | claimed |
| US-20090023215-A1 | Novel reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER (US) | 2009-01-22 | — | — | US | claimed |
| EP-2015780-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2009-01-21 | — | — | EP | claimed |
| WO-2007130073-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2007-11-15 | — | — | WO | claimed |
| US-12043639-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| WO-2024145435-A2 | LIPID COMPOSITIONS AND METHODS FOR DELIVERY TO IMMUNE CELLS | Life Technologies Corporation (US) | 2024-07-04 | — | — | WO | disclosed |
| CN-118271422-A | Transfection complexes and methods of use thereof | 分子传递有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-20240209390-A1 | PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME | MOLECULAR TRANSFER, INC. | 2024-06-27 | — | — | US | disclosed |
| EP-4384508-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-06-19 | — | — | EP | disclosed |
| EP-3341027-B1 | TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME | MOLECULAR TRANSFER INC (US) | 2024-03-06 | — | — | EP | disclosed |
| WO-2024031051-A1 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-02-08 | — | — | WO | disclosed |
| US-11866723-B2 | Plant virus movement proteins and methods of using same | Molecular Transfer Inc. (US) | 2024-01-09 | — | — | US | disclosed |
| WO-2024006937-A1 | LIPID COMPOSITIONS FOR IN VIVO DELIVERY | Life Technologies Corporation (US) | 2024-01-04 | — | — | WO | disclosed |
| US-20240000966-A1 | Lipid Compositions For In Vivo Delivery | Life Technologies Corporation | 2024-01-04 | — | — | US | disclosed |
| EP-4175967-A2 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation (US) | 2023-05-10 | — | — | EP | disclosed |
| WO-2023018990-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2023-02-16 | — | — | WO | disclosed |
| WO-2022006368-A2 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation (US) | 2022-01-06 | — | — | WO | disclosed |
| US-20220002716-A1 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation | 2022-01-06 | — | — | US | disclosed |
| US-20210323984-A1 | POL YCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. | 2021-10-21 | — | — | US | disclosed |
| US-11085056-B2 | Transfection complexes and methods of using the same | MOLECULAR TRANSFER, INC. (US) | 2021-08-10 | — | — | US | disclosed |
| US-20210189433-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer Inc. | 2021-06-24 | — | — | US | disclosed |
| US-10968240-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2021-04-06 | — | — | US | disclosed |
| US-10883118-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | Molecular Transfer Inc. (US) | 2021-01-05 | — | — | US | disclosed |
| US-20200283795-A1 | PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME | Molecular Transfer Inc. | 2020-09-10 | — | — | US | disclosed |
| US-20190352316-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2019-11-21 | — | — | US | disclosed |
| EP-2696678-B1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER INC (US) | 2019-11-20 | — | — | EP | disclosed |
| US-20190264230-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer Inc. | 2019-08-29 | — | — | US | disclosed |
| US-10155780-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2018-12-18 | — | — | US | disclosed |
| US-20180340188-A1 | TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME | MOLECULAR TRANSFER, INC. (US) | 2018-11-29 | — | — | US | disclosed |
| US-10138497-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2018-11-27 | — | — | US | disclosed |
| US-20180237790-A1 | FORMULATIONS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS TO PLANT CELLS | FORREST INNOVATIONS LTD. (IL) | 2018-08-23 | — | — | US | disclosed |
| EP-3334831-A1 | FORMULATIONS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS TO PLANT CELLS | Forrest Innovations Ltd. (IL) | 2018-06-20 | — | — | EP | disclosed |
| US-20180002724-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer Inc. | 2018-01-04 | — | — | US | disclosed |
| EP-2604255-B1 | Novel reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER INC (US) | 2017-10-25 | — | — | EP | disclosed |
| US-9765359-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-20170253888-A1 | PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING THE SAME | MOLECULAR TRANSFER, INC. | 2017-09-07 | — | — | US | disclosed |
| WO-2017025967-A1 | FORMULATIONS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS TO PLANT CELLS | FORREST INNOVATIONS LTD. (IL) | 2017-02-16 | — | — | WO | disclosed |
| US-20170029448-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2017-02-02 | — | — | US | disclosed |
| US-20160130607-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer Inc. | 2016-05-12 | — | — | US | disclosed |
| US-9259475-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2016-02-16 | — | — | US | disclosed |
| EP-2912045-A2 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2015-09-02 | — | — | EP | disclosed |
| US-20140213637-A1 | Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells | Molecular Transfer Inc. (US) | 2014-07-31 | — | — | US | disclosed |
| US-8759499-B2 | Lipids for transfection of Eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2014-06-24 | — | — | US | disclosed |
| WO-2014070687-A2 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2014-05-08 | — | — | WO | disclosed |
| EP-2696678-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2014-02-19 | — | — | EP | disclosed |
| WO-2013158127-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2013-10-24 | — | — | WO | disclosed |
| EP-2604255-A1 | Novel reagents for transfection of eukaryotic cells | Molecular Transfer, Inc. (US) | 2013-06-19 | — | — | EP | disclosed |
| EP-2015780-B1 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER INC (US) | 2012-12-12 | — | — | EP | disclosed |
| WO-2012142622-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2012-10-18 | — | — | WO | disclosed |
| US-20120052574-A1 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2012-03-01 | — | — | US | disclosed |
| US-20110200624-A1 | NOVEL PEPTIDES FOR USE IN TRANSFECTION | MOLECULAR TRANSFER, INC. (US) | 2011-08-18 | — | — | US | disclosed |
| US-7915230-B2 | Reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2011-03-29 | — | — | US | disclosed |
| WO-2010014915-A2 | NOVEL PEPTIDES FOR USE IN TRANSFECTION | MOLECULAR TRANSFER, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| US-20090023215-A1 | Novel reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER (US) | 2009-01-22 | — | — | US | disclosed |
| EP-2015780-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2009-01-21 | — | — | EP | disclosed |
| WO-2007130073-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
| WO-2007130073-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (23 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200283795-A1 | PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME | HDLBP, PHAX, PLTP | USP2 3364/4885GNAI3 534/4885GNAO1 2667/4885 |
| US-20180340188-A1 | TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME | TIAL1, NPC1L1, LIPA | USP2 4325/4885GNAI3 1083/4885GNAO1 3364/4885 |
| US-12043639-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | PHOSPHO1, MBOAT7, PLTP | USP2 3480/4885GNAI3 1825/4885GNAO1 3482/4885 |
| US-11866723-B2 | Plant virus movement proteins and methods of using same | HDLBP, PHAX, PLTP | USP2 3364/4885GNAI3 534/4885GNAO1 2667/4885 |
| US-10883118-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | SNRPE, POLRMT, PHAX | USP2 3732/4885GNAI3 1540/4885GNAO1 2845/4885 |
| US-20140213637-A1 | Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells | SNRPE, POLRMT, PHAX | USP2 3732/4885GNAI3 1540/4885GNAO1 2845/4885 |
| US-10968240-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | PHOSPHO1, MBOAT7, PLTP | USP2 3480/4885GNAI3 1825/4885GNAO1 3482/4885 |
| US-10138497-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | SNRPE, POLRMT, PHAX | USP2 3732/4885GNAI3 1540/4885GNAO1 2845/4885 |
| US-20240209390-A1 | PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME | HDLBP, PHAX, PLTP | USP2 3364/4885GNAI3 534/4885GNAO1 2667/4885 |
| US-10155780-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | PHOSPHO1, MBOAT7, PLTP | USP2 3696/4885GNAI3 1304/4885GNAO1 3143/4885 |
| US-20240000966-A1 | Lipid Compositions For In Vivo Delivery | CHMP4B, LIPA, CETP | USP2 2546/4885GNAI3 1144/4885GNAO1 3026/4885 |
| US-20170029448-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | PHOSPHO1, PLTP, MBOAT7 | USP2 3725/4885GNAI3 1147/4885GNAO1 3008/4885 |
| US-20220002716-A1 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | RNGTT, RNMT, CPSF7 | USP2 1235/4885GNAI3 1206/4885GNAO1 1580/4885 |
| US-20090023215-A1 | Novel reagents for transfection of eukaryotic cells | FUS, PHAX, PICALM | USP2 3503/4885GNAI3 1694/4885GNAO1 3683/4885 |
| US-11085056-B2 | Transfection complexes and methods of using the same | TIAL1, NPC1L1, LIPA | USP2 4325/4885GNAI3 1083/4885GNAO1 3364/4885 |
| US-20210189433-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | SNRPE, POLRMT, PHAX | USP2 3732/4885GNAI3 1540/4885GNAO1 2845/4885 |
| US-20190352316-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | PHOSPHO1, MBOAT7, PLTP | USP2 3480/4885GNAI3 1825/4885GNAO1 3482/4885 |
| US-20170253888-A1 | PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING THE SAME | HDLBP, PHAX, PLTP | USP2 3272/4885GNAI3 549/4885GNAO1 2652/4885 |
| US-20120052574-A1 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | FUS, PHAX, PICALM | USP2 3503/4885GNAI3 1694/4885GNAO1 3683/4885 |
| US-20160130607-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | SNRPE, POLRMT, PHAX | USP2 3732/4885GNAI3 1540/4885GNAO1 2845/4885 |
| US-20210323984-A1 | POL YCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | POLRMT, PHOSPHO1, MBOAT7 | USP2 3488/4885GNAI3 3293/4885GNAO1 4310/4885 |
| US-20190264230-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | SNRPE, POLRMT, PHAX | USP2 3732/4885GNAI3 1540/4885GNAO1 2845/4885 |
| US-20180002724-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | SNRPE, POLRMT, PHAX | USP2 3732/4885GNAI3 1540/4885GNAO1 2845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.